BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/21/2020 2:41:04 PM | Browse: 1154 | Download: 1706
 |
Received |
|
2020-05-04 15:36 |
|
Peer-Review Started |
|
2020-05-04 15:38 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-07-25 20:52 |
|
Revised |
|
2020-07-31 18:36 |
|
Second Decision |
|
2020-09-08 11:07 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-09-08 20:27 |
|
Articles in Press |
|
2020-09-08 20:27 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-10-14 00:13 |
|
Publish the Manuscript Online |
|
2020-10-21 14:41 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Albumin-bound paclitaxel as new treatment for metastatic cholangiocarcinoma: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Roberto Martin Huertas, Raquel Fuentes-Mateos, Juan Jose Serrano Domingo, Elena Corral de la Fuente and Mercedes Rodríguez-Garrote |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Roberto Martin Huertas, MD, N/A, N/A, Medical Oncology Department, Hospital Universitario Ramon y Cajal, Ctra. de Colmenar Viejo km. 9100, Madrid 28034, Spain. robertomartinhuertas@outlook.com |
| Key Words |
Cholangiocarcinoma; Chemotherapy; Albumin-bound paclitaxel; Case report; Metastatic; Clinical trial |
| Core Tip |
Cholangiocarcinomas are very aggressive tumors. Most patients have advanced-stage disease at presentation and the efficacy of systemic therapies for this setting is limited. Albumin bound paclitaxel (nab-paclitaxel) has been approved in some cancers but not in cholangiocarcinoma. We present a clinical case of metastatic cholangiocarcinoma treatment with second-line nab-paclitaxel and we review the preclinical and clinical evidence about its useful in these tumors. |
| Publish Date |
2020-10-21 14:41 |
| Citation |
Martin Huertas R, Fuentes-Mateos R, Serrano Domingo JJ, Corral de la Fuente E, Rodríguez-Garrote M. Albumin-bound paclitaxel as new treatment for metastatic cholangiocarcinoma: A case report. World J Clin Oncol 2020; 11(10): 844-853 |
| URL |
https://www.wjgnet.com/2218-4333/full/v11/i10/844.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v11.i10.844 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
